M
Michele Caraglia
Researcher at Seconda Università degli Studi di Napoli
Publications - 562
Citations - 24508
Michele Caraglia is an academic researcher from Seconda Università degli Studi di Napoli. The author has contributed to research in topics: Cancer & Cancer cell. The author has an hindex of 67, co-authored 525 publications receiving 20615 citations. Previous affiliations of Michele Caraglia include Temple University & Magna Græcia University.
Papers
More filters
Journal Article
Intraluminal gel ultrasound and eco-color doppler: new tools for the study of colorectal cancer in mice.
Antonio Barbieri,Maria Luisa Barretta,Domenica Rea,Carmine Picone,Olimpia Fabozzi,Giuseppe Palma,Luciano Antonio,Alessandro Federico,Sabrina Bimonte,Francesca Setola,Elisabetta de Lutio di Castelguidone,Maria Castellano,Adolfo Gallipoli D'Errico,Michele Caraglia,Claudio Arra +14 more
TL;DR: Ulster is a rapid examination compared to other diagnostic techniques that has a good sensitivity when the tumours reach the dimensions of 3 mm² or more and is able to detect only tumours with sizes ≥3 mm².
Journal ArticleDOI
A novel metronomic schedule of oral vinorelbine for the treatment of metastatic breast cancer in elderly patients: A phase II trial
R. Addeo,Vincenzo Faiola,Gregorio Cennamo,Rosario Guarrasi,Liliana Montella,Patrizia Iodice,Alessandro Sgambato,Elena Capasso,Michele Caraglia,S. Del Prete +9 more
TL;DR: Metronomic oral VNR can be safely administered to elderly patients with MBC and is active in this population, and the schedule was well tolerated.
Journal ArticleDOI
Highlights of the Annual Meeting of the Italian Association for Cell Cultures (AICC): new drug delivery strategies and technological platforms for diagnosis and therapy of tumors. Part II. 6 - 7 December 2007, Naples, Italy.
TL;DR: The crossing of the blood–brain barrier by pegylated liposomes in order to deliver antitumor drugs to brain tumor sites was explored and the pharmacokinetics and pharmaco-distribution of different carrier systems were explained.
Journal ArticleDOI
High-dose recombinant interleukin-2/verapamil combination in advanced cancer
Pierosandro Tagliaferri,Pierpaolo Correale,Michele Mottola,G. De Simone,Vincenzo Montesarchio,Elide Matano,A Rea,Alessandro Morabito,M. Famiani,Fortunato Ciardiello,Giampaolo Tortora,Michele Caraglia,C. Barile,Giovannella Palmieri,Ar Bianco +14 more
Journal ArticleDOI
Up-regulated EGF receptors undergo to rapid internalization and ubiquitin-dependent degradation in human cancer cells exposed to 8-Cl-cAMP
Michele Caraglia,E. Di Gennaro,D. Barbarulo,M. Marra,Pierosandro Tagliaferri,Alberto Abbruzzese,Alfredo Budillon +6 more
TL;DR: Analysis of epidermal growth factor‐dependent receptor internalization in 8‐Cl‐cAMP‐treated cells showed a higher endocytosis rate as well as an accelerated degradation which occurred together with an increased receptor ubiquitination, suggesting its combination with agents that disrupt epiderm growth factor receptor signalling.